Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1212: Plaque-associated and circulating miRNAs reveal distinct molecular responses in ACS and CCS patients undergoing PCI

Presenter: Jacopo Sabbatinelli

October 27, 2025

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2023

TCT 60: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry)

Presenter: Wojciech Wanha

October 24, 2023

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

Presentation TCT 2013

Intervention in Multiple Sclerosis for Chronic Cerebral Spinal Venous Insufficiency (CCSVI): Is It Worth the Effort Involved to Test It?

Presenter: Sumaira Macdonald

October 27, 2013

News Conference News TCT 2012

Debate Continues with the AUC

October 26, 2012

Presentation TCT 2012

Update on CCSVI: Are We Any Closer to Understanding This Entity and Its Therapy?

Presenter: Michael Dake

October 22, 2012

Advertisement

TCT 1212: Plaque-associated and circulating miRNAs reveal distinct molecular responses in ACS and CCS patients undergoing PCI

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

TCT 60: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry)

More DAPT Duration Data, More Calls to Tailor to Individual Patients

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Intervention in Multiple Sclerosis for Chronic Cerebral Spinal Venous Insufficiency (CCSVI): Is It Worth the Effort Involved to Test It?

Debate Continues with the AUC

Update on CCSVI: Are We Any Closer to Understanding This Entity and Its Therapy?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content